Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Innovative Oral Contraception Program Targets Growing Wild Boar Issue

(IN BRIEF) Researchers are launching a pioneering initiative to address the surging wild boar population across parts of Europe by administering oral contraception to the animals. With numbers of wild boar escalating rapidly and posing significant economic and environmental threats, … Read the full press release

Eni Foundation Launches Mobile Clinics Initiative to Enhance Healthcare in Remote Algerian Regions

(IN BRIEF) Eni Foundation, in collaboration with the Algerian Ministry of Health, Population and Hospital Reform, has initiated a project aimed at bolstering healthcare services in remote regions of Algeria. The endeavor, unveiled during a ceremony in Algiers, saw the … Read the full press release

Continuity and Strategy: Fresenius Management SE Proactively Extends CFO Sara Hennicken’s Mandate

(IN BRIEF) Fresenius Management SE has extended Sara Hennicken’s term as Chief Financial Officer (CFO) until 2027, two years earlier than planned, to ensure continuity in advancing the #FutureFresenius strategy. Hennicken, who joined Fresenius in 2019, has been instrumental in … Read the full press release

Fresenius Medical Care Employees Garner Prestigious Awards for Contributions to Renal Health

(IN BRIEF) Fresenius Medical Care, a leading provider of products and services for renal diseases, celebrates International Women’s Day by honoring three exceptional employees for their outstanding achievements. Ana Catalina Alvarez Elias, a Research Scientist, has been recognized as an … Read the full press release

FDA Gives Nod to Fresenius Kabi’s Tyenne®: A Dual-Format Tocilizumab Biosimilar Advancement

(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations. This marks a significant milestone in the company’s growth strategy (#FutureFresenius) and expands treatment options for inflammatory, autoimmune diseases, and … Read the full press release

GSK Reports Positive Results from DREAMM-8 Phase III Trial of Blenrep in Multiple Myeloma Treatment

(IN BRIEF) GSK has announced encouraging findings from the interim analysis of the DREAMM-8 phase III trial evaluating Blenrep (belantamab mafodotin) in combination with pomalidomide plus dexamethasone (PomDex) compared to the standard of care, bortezomib plus PomDex, for relapsed or … Read the full press release

Novo Nordisk Hosts Capital Markets Day to Share Progress on Strategic Aspirations 2025

(IN BRIEF) Novo Nordisk is conducting a Capital Markets Day (CMD) to provide updates on its Strategic Aspirations 2025. The event will focus on various aspects, including corporate strategy, sustainability, research and development pipeline, and financial performance. Highlights include discussions … Read the full press release

Philips Tops Clarivate’s 2024 Global Innovator List for 11th Consecutive Year

(IN BRIEF) Royal Philips, a prominent figure in health technology, has once again secured its position in the 2024 Clarivate Top 100 Global Innovator™ list, marking its eleventh consecutive inclusion. With a dedication to R&D programs and collaborative efforts, Philips … Read the full press release

Biotech Acceleration: Evotec and Claris Ventures Unite to Propel Portfolio Companies Forward

(IN BRIEF) Evotec and Claris Ventures have formed a strategic partnership to accelerate the progress of biotech ventures in Claris’s portfolio into clinical trials. This collaboration allows Claris’s portfolio companies, focused on biotech ventures nearing clinical trials, streamlined access to … Read the full press release

Novo Nordisk’s Semaglutide Shows Promise in Kidney Outcomes Trial FLOW

(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0 mg with placebo as an adjunct to standard care for people with type 2 diabetes and chronic kidney disease (CKD). … Read the full press release

What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness

(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

EMA Validates Marketing Authorisation Applications for AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan in Lung and Breast Cancer Treatment

(IN BRIEF) The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for datopotamab deruxtecan (Dato-DXd), developed by AstraZeneca and Daiichi Sankyo, for the treatment of nonsquamous non-small cell lung cancer (NSCLC) and hormone receptor (HR)-positive, HER2-negative breast … Read the full press release

Empathetic Communication Found Effective in Addressing Vaccine Hesitancy, Study Shows

(IN BRIEF) A groundbreaking international study led by the University of Bristol reveals the effectiveness of empathetic correction of misinformation in improving attitudes towards vaccination, particularly among vaccine-hesitant individuals. The research, published in Health Psychology, highlights the significance of empathetic … Read the full press release

Genetic Study Reveals Potential for Tailored Breast Cancer Screening

(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could revolutionize breast cancer screening, potentially benefiting one in ten women. The study indicates that a comprehensive genetic risk profile could … Read the full press release

Prosus Ventures Backs Kismet with $8.2M Seed Investment for Healthcare Innovation

(IN BRIEF) Kismet, a healthcare startup, has secured $8.2 million in seed funding led by Prosus Ventures and Airtree Ventures, bringing its total financing to $10.8 million since its founding in February 2023. The funding will accelerate Kismet’s mission to … Read the full press release

Novartis Unveils Promising Results from SMART Study: Zolgensma’s Efficacy Confirmed in Older and Heavier SMA Patients

(IN BRIEF) Novartis has presented compelling data from the SMART study, reinforcing the clinical advantages of Zolgensma® (onasemnogene abeparvovec) in treating spinal muscular atrophy (SMA) patients weighing ≥ 8.5 kg to ≤ 21 kg, with a mean age of 4.69 … Read the full press release

The European companies at MWC Barcelona 2024: AI, 5G, VR, XR, Cybersecurity, Digital Transformation, Entertainment, etc.

(IN BRIEF) At the Mobile World Congress (MWC) Barcelona 2024, European companies showcased a wide array of innovations and strategic partnerships that underscored their commitment to driving digital transformation and enhancing connectivity across various sectors. The key topics discussed by … Read the full press release

Driving Innovation: Henkel Spotlights Self-Regulating PTC Heaters and More at LOPEC 2024

(IN BRIEF) Henkel, a leading provider of printed electronics materials, is set to showcase its latest innovations at the LOPEC trade show. They will unveil their functional materials tailored for smart surfaces, healthcare, and connectivity applications. The focus will be … Read the full press release

Eckert & Ziegler’s GalliaPharm® Generator Powers Groundbreaking Cancer Diagnostic Trial in Japan

(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release